Sangamo Therapeutics France Revenue

Biotechnology Research • Valbonne, Provence-Alpes-Côte d'Azur, France • 1-10 Employees

Sangamo Therapeutics France revenue & valuation

Annual revenue	$769,995
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$2,500,000
Total funding	No funding

Key Contact at Sangamo Therapeutics France

Estelle Piccapane

Associate Director Human Resources, Europe

Company overview

Headquarters	Allée de la Nertière, Les Cardoulines HT1, Valbonne, Nice area 06560, FR
Website	sangamo.com
NAICS	541714
Keywords	Biotechnology, Research, Genomic Engineering
Founded	1995
Employees	1-10
Socials

Sangamo Therapeutics France Email Formats

Sangamo Therapeutics France uses 2 email formats. The most common is {first initial}{last name} (e.g., jdoe@sangamo.com), used 50% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@sangamo.com	50%
{first name}{last name}	johndoe@sangamo.com	50%

About Sangamo Therapeutics France

Sangamo Therapeutics France is the French subsidiary of Sangamo Therapeutics Inc. Sangamo Therapeutics, Inc. is focused on translating ground-breaking science into genomic medicines with the potential to transform patients' lives using gene therapy, ex vivo gene-edited cell therapy, in vivo genome editing, and gene regulation. For more information about Sangamo, visit www.sangamo.com. Sangamo Therapeutics France was formerly TxCell and was acquired by Sangamo Q4 2018.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Entry

Manager

Director

Employees by Department

Sangamo Therapeutics France has 7 employees across 5 departments.

Departments

Number of employees

Funding Data

Sangamo Therapeutics France has never raised funding before.

Frequently asked questions

Sangamo Therapeutics France is located in Valbonne, Provence-Alpes-Côte d'Azur, FR.

Sangamo Therapeutics France generates an estimated annual revenue of $769,995. This revenue figure reflects the company's market position and business performance in its industry.

Sangamo Therapeutics France has an estimated valuation of $2,500,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Sangamo Therapeutics France was founded in 1995, making it 31 years old. The company has established itself as a significant player in its industry over this time.

Sangamo Therapeutics France has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Sangamo Therapeutics France

Estelle Piccapane

Associate Director Human Resources, Europe

4.8

40,000 users